Enteral stenting in the management of obstructing colonic cancer: the city hospital experience

Introduction Endoscopic colonic stenting has an emerging role in the non-operative management of patients with obstructing lesions.1 The use of colonic stenting as a bridge to surgery has decreased the requirement for emergency surgery which has a high morbidity and mortality.2 It also reduces the n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 2011-04, Vol.60 (Suppl 1), p.A70-A71
Hauptverfasser: Mozdiak, E A, Lewis, M J V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A71
container_issue Suppl 1
container_start_page A70
container_title Gut
container_volume 60
creator Mozdiak, E A
Lewis, M J V
description Introduction Endoscopic colonic stenting has an emerging role in the non-operative management of patients with obstructing lesions.1 The use of colonic stenting as a bridge to surgery has decreased the requirement for emergency surgery which has a high morbidity and mortality.2 It also reduces the need for colostomy formation. It can provide palliation for patients unsuitable for surgery3 and has a useful role in benign disease. City Hospital in Birmingham, has been performing colonic stenting since 2004. We reviewed the success rates and complications at our site, and compared with the literature. Methods 61 patients were listed for colonic stenting between March 2004 and November 2010. After case-note review, data was collected on demographics, indication for stent, success rates, complications, further treatment and 30-day plus 90-day mortality. A literature search was undertaken to ascertain the published success and complication rates, and compare with our results. Results 66% were male, average age 75 (49–95) years. 76% of patients required palliative stenting. 87% had left-sided tumours, the majority (54%) in the sigmoid colon. 46 patients had a successfully placed stent. 30 and 90-day mortality was 16% and 44% respectively. Median survival was 124 days. Perforation occurred in 2 (4.5%) patients, stent migration occurred in 1 (2.25%). 9 (15%) patients underwent stenting as a bridge to surgery, 77% of these underwent elective surgery at a later date. 31% of patients underwent palliative chemotherapy/radiotherapy after successful stenting, 29% had no further treatment. 19% of the stented group went on to have a stoma formed, compared with 54% of the non-stented group. Conclusion Colonic stenting is safe and effective at alleviating the symptoms of obstructing colonic cancer.4 It provides acute decompression avoiding emergency surgery in often frail, high-risk patients.5 It has a palliative role in non-operable disease.3 Stoma formation is associated with higher morbidity rates. Our data indicates a much lower stoma formation rate in the stented group. The literature documents perforation rates of 2–10% and stent migration rate of 4–10%.6 7 Colonic stenting at City Hospital is successful, with low complication rates. It should be considered more readily in appropriate patients.
doi_str_mv 10.1136/gut.2011.239301.143
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753460396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1753460396</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2773-ccadcb3bea0d3717dc0bf066a8a1b03af0f06d5228eee40b26dce6c22cf651993</originalsourceid><addsrcrecordid>eNqNkE2P1SAUhonRxOvoL3DTxI2b1gO0QN3pdfxIRt2MmriQUHp6h2sLV6DJzL-XmRoXrlwR4Hnfc_IQ8pRCQykXLw5rbhhQ2jDec6ANbfk9sqOtUDVnSt0nOwAq6062_UPyKKUjACjV0x35ce4zRjNXKaPPzh8q56t8hdVivDngUh6rMFVhSDmu9g6wYQ7e2coabzG-vKOtyzfVVUgnl0sXXp8wOizfj8mDycwJn_w5z8iXt-eX-_f1xed3H_avLuqBSclra81oBz6ggZFLKkcLwwRCGGXoANxMUG5jx5hCxBYGJkaLwjJmJ9HRvudn5PnWe4rh14op68Uli_NsPIY1aSo73grgvSjos3_QY1ijL9tpBlxJzqWCQvGNsjGkFHHSp-gWE280BX3rXBfn-ta53pzr4ryk6i3lis7rvxETf2ohuez0p697_frNt-_842WraeGbjR-W438N-A1Iw5OW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038733780</pqid></control><display><type>article</type><title>Enteral stenting in the management of obstructing colonic cancer: the city hospital experience</title><source>BMJ Journals - NESLi2</source><source>PubMed Central</source><creator>Mozdiak, E A ; Lewis, M J V</creator><creatorcontrib>Mozdiak, E A ; Lewis, M J V</creatorcontrib><description>Introduction Endoscopic colonic stenting has an emerging role in the non-operative management of patients with obstructing lesions.1 The use of colonic stenting as a bridge to surgery has decreased the requirement for emergency surgery which has a high morbidity and mortality.2 It also reduces the need for colostomy formation. It can provide palliation for patients unsuitable for surgery3 and has a useful role in benign disease. City Hospital in Birmingham, has been performing colonic stenting since 2004. We reviewed the success rates and complications at our site, and compared with the literature. Methods 61 patients were listed for colonic stenting between March 2004 and November 2010. After case-note review, data was collected on demographics, indication for stent, success rates, complications, further treatment and 30-day plus 90-day mortality. A literature search was undertaken to ascertain the published success and complication rates, and compare with our results. Results 66% were male, average age 75 (49–95) years. 76% of patients required palliative stenting. 87% had left-sided tumours, the majority (54%) in the sigmoid colon. 46 patients had a successfully placed stent. 30 and 90-day mortality was 16% and 44% respectively. Median survival was 124 days. Perforation occurred in 2 (4.5%) patients, stent migration occurred in 1 (2.25%). 9 (15%) patients underwent stenting as a bridge to surgery, 77% of these underwent elective surgery at a later date. 31% of patients underwent palliative chemotherapy/radiotherapy after successful stenting, 29% had no further treatment. 19% of the stented group went on to have a stoma formed, compared with 54% of the non-stented group. Conclusion Colonic stenting is safe and effective at alleviating the symptoms of obstructing colonic cancer.4 It provides acute decompression avoiding emergency surgery in often frail, high-risk patients.5 It has a palliative role in non-operable disease.3 Stoma formation is associated with higher morbidity rates. Our data indicates a much lower stoma formation rate in the stented group. The literature documents perforation rates of 2–10% and stent migration rate of 4–10%.6 7 Colonic stenting at City Hospital is successful, with low complication rates. It should be considered more readily in appropriate patients.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>DOI: 10.1136/gut.2011.239301.143</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Cancer ; Chemotherapy ; Colon ; colonic stenting ; Colorectal cancer ; Decompression ; Demography ; Implants ; Migration ; Morbidity ; Mortality ; Ostomy ; Palliation ; Patients ; Radiation therapy ; Risk groups ; Success ; Surgery ; Tumors</subject><ispartof>Gut, 2011-04, Vol.60 (Suppl 1), p.A70-A71</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b2773-ccadcb3bea0d3717dc0bf066a8a1b03af0f06d5228eee40b26dce6c22cf651993</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://gut.bmj.com/content/60/Suppl_1/A70.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://gut.bmj.com/content/60/Suppl_1/A70.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77472,77503</link.rule.ids></links><search><creatorcontrib>Mozdiak, E A</creatorcontrib><creatorcontrib>Lewis, M J V</creatorcontrib><title>Enteral stenting in the management of obstructing colonic cancer: the city hospital experience</title><title>Gut</title><addtitle>Gut</addtitle><description>Introduction Endoscopic colonic stenting has an emerging role in the non-operative management of patients with obstructing lesions.1 The use of colonic stenting as a bridge to surgery has decreased the requirement for emergency surgery which has a high morbidity and mortality.2 It also reduces the need for colostomy formation. It can provide palliation for patients unsuitable for surgery3 and has a useful role in benign disease. City Hospital in Birmingham, has been performing colonic stenting since 2004. We reviewed the success rates and complications at our site, and compared with the literature. Methods 61 patients were listed for colonic stenting between March 2004 and November 2010. After case-note review, data was collected on demographics, indication for stent, success rates, complications, further treatment and 30-day plus 90-day mortality. A literature search was undertaken to ascertain the published success and complication rates, and compare with our results. Results 66% were male, average age 75 (49–95) years. 76% of patients required palliative stenting. 87% had left-sided tumours, the majority (54%) in the sigmoid colon. 46 patients had a successfully placed stent. 30 and 90-day mortality was 16% and 44% respectively. Median survival was 124 days. Perforation occurred in 2 (4.5%) patients, stent migration occurred in 1 (2.25%). 9 (15%) patients underwent stenting as a bridge to surgery, 77% of these underwent elective surgery at a later date. 31% of patients underwent palliative chemotherapy/radiotherapy after successful stenting, 29% had no further treatment. 19% of the stented group went on to have a stoma formed, compared with 54% of the non-stented group. Conclusion Colonic stenting is safe and effective at alleviating the symptoms of obstructing colonic cancer.4 It provides acute decompression avoiding emergency surgery in often frail, high-risk patients.5 It has a palliative role in non-operable disease.3 Stoma formation is associated with higher morbidity rates. Our data indicates a much lower stoma formation rate in the stented group. The literature documents perforation rates of 2–10% and stent migration rate of 4–10%.6 7 Colonic stenting at City Hospital is successful, with low complication rates. It should be considered more readily in appropriate patients.</description><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Colon</subject><subject>colonic stenting</subject><subject>Colorectal cancer</subject><subject>Decompression</subject><subject>Demography</subject><subject>Implants</subject><subject>Migration</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Ostomy</subject><subject>Palliation</subject><subject>Patients</subject><subject>Radiation therapy</subject><subject>Risk groups</subject><subject>Success</subject><subject>Surgery</subject><subject>Tumors</subject><issn>0017-5749</issn><issn>1468-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkE2P1SAUhonRxOvoL3DTxI2b1gO0QN3pdfxIRt2MmriQUHp6h2sLV6DJzL-XmRoXrlwR4Hnfc_IQ8pRCQykXLw5rbhhQ2jDec6ANbfk9sqOtUDVnSt0nOwAq6062_UPyKKUjACjV0x35ce4zRjNXKaPPzh8q56t8hdVivDngUh6rMFVhSDmu9g6wYQ7e2coabzG-vKOtyzfVVUgnl0sXXp8wOizfj8mDycwJn_w5z8iXt-eX-_f1xed3H_avLuqBSclra81oBz6ggZFLKkcLwwRCGGXoANxMUG5jx5hCxBYGJkaLwjJmJ9HRvudn5PnWe4rh14op68Uli_NsPIY1aSo73grgvSjos3_QY1ijL9tpBlxJzqWCQvGNsjGkFHHSp-gWE280BX3rXBfn-ta53pzr4ryk6i3lis7rvxETf2ohuez0p697_frNt-_842WraeGbjR-W438N-A1Iw5OW</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Mozdiak, E A</creator><creator>Lewis, M J V</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20110401</creationdate><title>Enteral stenting in the management of obstructing colonic cancer: the city hospital experience</title><author>Mozdiak, E A ; Lewis, M J V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2773-ccadcb3bea0d3717dc0bf066a8a1b03af0f06d5228eee40b26dce6c22cf651993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Colon</topic><topic>colonic stenting</topic><topic>Colorectal cancer</topic><topic>Decompression</topic><topic>Demography</topic><topic>Implants</topic><topic>Migration</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Ostomy</topic><topic>Palliation</topic><topic>Patients</topic><topic>Radiation therapy</topic><topic>Risk groups</topic><topic>Success</topic><topic>Surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mozdiak, E A</creatorcontrib><creatorcontrib>Lewis, M J V</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mozdiak, E A</au><au>Lewis, M J V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enteral stenting in the management of obstructing colonic cancer: the city hospital experience</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>60</volume><issue>Suppl 1</issue><spage>A70</spage><epage>A71</epage><pages>A70-A71</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><abstract>Introduction Endoscopic colonic stenting has an emerging role in the non-operative management of patients with obstructing lesions.1 The use of colonic stenting as a bridge to surgery has decreased the requirement for emergency surgery which has a high morbidity and mortality.2 It also reduces the need for colostomy formation. It can provide palliation for patients unsuitable for surgery3 and has a useful role in benign disease. City Hospital in Birmingham, has been performing colonic stenting since 2004. We reviewed the success rates and complications at our site, and compared with the literature. Methods 61 patients were listed for colonic stenting between March 2004 and November 2010. After case-note review, data was collected on demographics, indication for stent, success rates, complications, further treatment and 30-day plus 90-day mortality. A literature search was undertaken to ascertain the published success and complication rates, and compare with our results. Results 66% were male, average age 75 (49–95) years. 76% of patients required palliative stenting. 87% had left-sided tumours, the majority (54%) in the sigmoid colon. 46 patients had a successfully placed stent. 30 and 90-day mortality was 16% and 44% respectively. Median survival was 124 days. Perforation occurred in 2 (4.5%) patients, stent migration occurred in 1 (2.25%). 9 (15%) patients underwent stenting as a bridge to surgery, 77% of these underwent elective surgery at a later date. 31% of patients underwent palliative chemotherapy/radiotherapy after successful stenting, 29% had no further treatment. 19% of the stented group went on to have a stoma formed, compared with 54% of the non-stented group. Conclusion Colonic stenting is safe and effective at alleviating the symptoms of obstructing colonic cancer.4 It provides acute decompression avoiding emergency surgery in often frail, high-risk patients.5 It has a palliative role in non-operable disease.3 Stoma formation is associated with higher morbidity rates. Our data indicates a much lower stoma formation rate in the stented group. The literature documents perforation rates of 2–10% and stent migration rate of 4–10%.6 7 Colonic stenting at City Hospital is successful, with low complication rates. It should be considered more readily in appropriate patients.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><doi>10.1136/gut.2011.239301.143</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 2011-04, Vol.60 (Suppl 1), p.A70-A71
issn 0017-5749
1468-3288
language eng
recordid cdi_proquest_miscellaneous_1753460396
source BMJ Journals - NESLi2; PubMed Central
subjects Cancer
Chemotherapy
Colon
colonic stenting
Colorectal cancer
Decompression
Demography
Implants
Migration
Morbidity
Mortality
Ostomy
Palliation
Patients
Radiation therapy
Risk groups
Success
Surgery
Tumors
title Enteral stenting in the management of obstructing colonic cancer: the city hospital experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A30%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enteral%20stenting%20in%20the%20management%20of%20obstructing%20colonic%20cancer:%20the%20city%20hospital%20experience&rft.jtitle=Gut&rft.au=Mozdiak,%20E%20A&rft.date=2011-04-01&rft.volume=60&rft.issue=Suppl%201&rft.spage=A70&rft.epage=A71&rft.pages=A70-A71&rft.issn=0017-5749&rft.eissn=1468-3288&rft_id=info:doi/10.1136/gut.2011.239301.143&rft_dat=%3Cproquest_cross%3E1753460396%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2038733780&rft_id=info:pmid/&rfr_iscdi=true